NewUser_DFnsii

SINOPEC CORP

XINKONG INT CAP

SHANGHAI PECHEM

GWMOTOR

SHANGSHAN GOLD

YUZHOU GROUP

FSE LIFESTYLE

JNBY

CHINA TRAVEL HK

ND PAPER

LEE & MAN PAPER

SUNSHINE PAPER

CHENMING PAPER

Pulp and Paper

<p>Stevens Capital Management LP has completely exited its position in Eli Lilly, selling all 12,036 shares in Q2 2025 for approximately $9.94 million. Following this sale, the fund's top holdings include Strategy ($35.09 million), CME Group ($20.69 million), and Apple ($19.38 million). Eli Lilly's stock has underperformed the S&P 500 by 38.3 percentage points over the past year, with a total return of -23.1%. The company, valued at $658.15 billion, continues to compete in the weight-loss drug market against Novo Nordisk.</p>

Motley Fool

Eli Lilly

Stevens Capital Closes Out Position in Eli Lilly